Sanofi pasteur is the vaccine division of sanofi-aventis Group. It is the largest company in the world devoted entirely to vaccines.
In 2004, Aventis merged with and into Sanofi. The new sanofi-aventis
Group became the world's 3rd largest pharmaceutical company. Aventis Pasteur, the vaccine division of sanofi-aventis Group, changed its name to sanofi pasteur.
- 1897, Marcel Mérieux creates the Mérieux Biological Institute in Lyon. Richard Slee creates the Pocono Biological Laboratories, in Swiftwater, Pennsylvania in the US
- 1914, John FitzGerald creates Connaught Laboratories, part of the University of Toronto.
- 1968, Rhône-Poulenc acquires 51% of the capital of the Institut Mérieux.
- 1974, Pasteur Institute creates Pasteur Production, a subsidiary specializing in manufacturing vaccines
- 1978, Connaught Laboratories in Canada acquires the vaccine manufacturing facility (Merrell-National Laboratories) at Swiftwater, Pennsylvania, US.
- 1985, Pasteur Production, the vaccines branch of the Institut Pasteur, is acquired by the Mérieux Institute, and Pasteur Vaccins is created
- 1989, The Mérieux Institute acquires the Connaught Laboratories in Canada and its subsidiaries and becomes a world leader in human biology
- 1990, Creation of Pasteur Mérieux Serums & Vaccins
- 1994, Pasteur Mérieux Sérums & Vaccins becomes a wholly owned subsidiary of Rhône-Poulenc.
- 1996, Pasteur Mérieux Connaught is the new name of Pasteur Mérieux Serums et Vaccins
- 1999, Rhône-Poulenc and Hoechst unite their Life Sciences activities in a single company, which takes on the name Aventis. Within this group, Pasteur Mérieux Connaught changes its name to Aventis Pasteur.
- 2004, merger of Aventis with and into Sanofi. The new sanofi-aventis Group becomes the world's 3rd largest pharmaceutical company, behind Pfizer and GlaxoSmithKline. Aventis Pasteur, the vaccine division of the sanofi-aventis Group, changes its name to sanofi pasteur.
Key facts & figures in 2006
- Sanofi pasteur - 2006 net sales: € 2,533 millions (+22.7% over 2005)
- Staff: nearly 10,000 employees
- More than a billion doses of vaccines provided to immunize more than 500 million people in the world
- A wide range of vaccines protecting against 20 bacterial and viral diseases
- A global presence
- More than US$ 1 million invested every day in R&D
- Headquarters: Lyon, France
- US Manufacturing Site: Swiftwater, PA
- TheraCys - bladder cancer
- ADACEL (Tdap) - diphtheria, tetanus and pertussis
- DAPTACEL (DTaP) - diphtheria, tetanus and pertussis
- Diphtheria and Tetanus Toxoids Adsorbed USP, diphtheria, tetanus and pertussis
- Tetanus Toxoid Adsorbed - diphtheria, tetanus and pertussis
- TriHIBit (DTaP/Hib Booster Use) - diphtheria, tetanus and pertussis and haemophilus influenzae type b
- Tripedia (DTaP vaccine) - diphtheria, tetanus, pertussis
- ActHIB - haemophilus influenzae type b
- Fluzone, Influenza Virus Vaccine - influenza
- Fluzone, Influenza Virus Vaccine, No Preservative - influenza
- Fluzone, Influenza Virus Vaccine, No Preservative: Ped Dose - influenza
- Menactra - meningococcal
- Menomune-A/C/Y/W-135 - meningococcal
- IPOL - Polio
- Imogam Rabies-HT - rabies immune globulin
- IMOVAX RABIES - rabies
- DECAVAC - tetanus and diphtheria
- Tetanus Toxoid Adsorbed - tetanus
- Tetanus Toxoid For Booster Use Only - tetanus
- JE-VAX - Japanese encephalitis virus
- Typhim Vi - typhoid fever
- YF-VAX - yellow fever
- Tubersol - tuberculosis